130 related articles for article (PubMed ID: 23290132)
1. Memoirs of a reincarnated T cell.
Crompton JG; Rao M; Restifo NP
Cell Stem Cell; 2013 Jan; 12(1):6-8. PubMed ID: 23290132
[TBL] [Abstract][Full Text] [Related]
2. Regeneration of human tumor antigen-specific T cells from iPSCs derived from mature CD8(+) T cells.
Vizcardo R; Masuda K; Yamada D; Ikawa T; Shimizu K; Fujii S; Koseki H; Kawamoto H
Cell Stem Cell; 2013 Jan; 12(1):31-6. PubMed ID: 23290135
[TBL] [Abstract][Full Text] [Related]
3. Generation of highly proliferative, rejuvenated cytotoxic T cell clones through pluripotency reprogramming for adoptive immunotherapy.
Kawai Y; Kawana-Tachikawa A; Kitayama S; Ueda T; Miki S; Watanabe A; Kaneko S
Mol Ther; 2021 Oct; 29(10):3027-3041. PubMed ID: 34023508
[TBL] [Abstract][Full Text] [Related]
4. Generation of rejuvenated antigen-specific T cells by reprogramming to pluripotency and redifferentiation.
Nishimura T; Kaneko S; Kawana-Tachikawa A; Tajima Y; Goto H; Zhu D; Nakayama-Hosoya K; Iriguchi S; Uemura Y; Shimizu T; Takayama N; Yamada D; Nishimura K; Ohtaka M; Watanabe N; Takahashi S; Iwamoto A; Koseki H; Nakanishi M; Eto K; Nakauchi H
Cell Stem Cell; 2013 Jan; 12(1):114-26. PubMed ID: 23290140
[TBL] [Abstract][Full Text] [Related]
5. A Safeguard System for Induced Pluripotent Stem Cell-Derived Rejuvenated T Cell Therapy.
Ando M; Nishimura T; Yamazaki S; Yamaguchi T; Kawana-Tachikawa A; Hayama T; Nakauchi Y; Ando J; Ota Y; Takahashi S; Nishimura K; Ohtaka M; Nakanishi M; Miles JJ; Burrows SR; Brenner MK; Nakauchi H
Stem Cell Reports; 2015 Oct; 5(4):597-608. PubMed ID: 26321144
[TBL] [Abstract][Full Text] [Related]
6. Generation of two induced pluripotent stem cell lines (MUSIi011-A and MUSIi011-B) from peripheral blood T lymphocytes of a healthy individual.
Netsrithong R; Promnakhon N; Boonkaew B; Vatanashevanopakorn C; Pattanapanyasat K; Wattanapanitch M
Stem Cell Res; 2019 Aug; 39():101487. PubMed ID: 31229899
[TBL] [Abstract][Full Text] [Related]
7. Sustainable Tumor-Suppressive Effect of iPSC-Derived Rejuvenated T Cells Targeting Cervical Cancers.
Honda T; Ando M; Ando J; Ishii M; Sakiyama Y; Ohara K; Toyota T; Ohtaka M; Masuda A; Terao Y; Nakanishi M; Nakauchi H; Komatsu N
Mol Ther; 2020 Nov; 28(11):2394-2405. PubMed ID: 32710827
[TBL] [Abstract][Full Text] [Related]
8. Generation of Antigen-Specific T Cells from Human Induced Pluripotent Stem Cells.
Nishimura T; Nakauchi H
Methods Mol Biol; 2019; 1899():25-40. PubMed ID: 30649763
[TBL] [Abstract][Full Text] [Related]
9. 'Off-the-shelf' immunotherapy with iPSC-derived rejuvenated cytotoxic T lymphocytes.
Ando M; Nakauchi H
Exp Hematol; 2017 Mar; 47():2-12. PubMed ID: 27826124
[TBL] [Abstract][Full Text] [Related]
10. Generation of Tumor Antigen-Specific Cytotoxic T Lymphocytes from Pluripotent Stem Cells.
Chen X; Lei F; Wang L; Xiong X; Song J
Methods Mol Biol; 2019; 1884():43-55. PubMed ID: 30465194
[TBL] [Abstract][Full Text] [Related]
11. Generation of Pure Highly Functional Human Anti-Tumor Specific Cytotoxic T Lymphocytes With Stem Cell-Like Memory Features for Melanoma Immunotherapy.
Hamieh M; Chatillon JF; Dupel E; Bayeux F; Fauquembergue E; Maby P; Drouet A; Duval-Modeste AB; Adriouch S; Boyer O; Latouche JB
Front Immunol; 2021; 12():674276. PubMed ID: 34566953
[TBL] [Abstract][Full Text] [Related]
12. Differentiating CD8αβ T Cells from TCR-Transduced iPSCs for Cancer Immunotherapy.
Minagawa A; Kaneko S
Methods Mol Biol; 2019; 2048():81-84. PubMed ID: 31396932
[TBL] [Abstract][Full Text] [Related]
13. Generation of induced pluripotent stem cells from human terminally differentiated circulating T cells.
Seki T; Yuasa S; Oda M; Egashira T; Yae K; Kusumoto D; Nakata H; Tohyama S; Hashimoto H; Kodaira M; Okada Y; Seimiya H; Fusaki N; Hasegawa M; Fukuda K
Cell Stem Cell; 2010 Jul; 7(1):11-4. PubMed ID: 20621043
[No Abstract] [Full Text] [Related]
14. The Generation of Human γδT Cell-Derived Induced Pluripotent Stem Cells from Whole Peripheral Blood Mononuclear Cell Culture.
Watanabe D; Koyanagi-Aoi M; Taniguchi-Ikeda M; Yoshida Y; Azuma T; Aoi T
Stem Cells Transl Med; 2018 Jan; 7(1):34-44. PubMed ID: 29164800
[TBL] [Abstract][Full Text] [Related]
15. Redifferentiation of Adaptive Naïve-Like CTL from T-Cell-Derived iPSC.
Kawai Y; Kaneko S
Methods Mol Biol; 2019; 2048():71-75. PubMed ID: 31396930
[TBL] [Abstract][Full Text] [Related]
16. Differentiation of blood T cells: Reprogramming human induced pluripotent stem cells into neuronal cells.
Tsai PH; Chang YC; Lee YY; Ko YL; Yang YH; Lin CF; Chang YL; Yu WC; Shih YH; Chen MT
J Chin Med Assoc; 2015 Jun; 78(6):353-9. PubMed ID: 26022695
[TBL] [Abstract][Full Text] [Related]
17. Induced Pluripotent Stem Cell-Derived T Cells for Cancer Immunotherapy.
Patel SJ; Yamauchi T; Ito F
Surg Oncol Clin N Am; 2019 Jul; 28(3):489-504. PubMed ID: 31079802
[TBL] [Abstract][Full Text] [Related]
18. A clinically applicable and scalable method to regenerate T-cells from iPSCs for off-the-shelf T-cell immunotherapy.
Iriguchi S; Yasui Y; Kawai Y; Arima S; Kunitomo M; Sato T; Ueda T; Minagawa A; Mishima Y; Yanagawa N; Baba Y; Miyake Y; Nakayama K; Takiguchi M; Shinohara T; Nakatsura T; Yasukawa M; Kassai Y; Hayashi A; Kaneko S
Nat Commun; 2021 Jan; 12(1):430. PubMed ID: 33462228
[TBL] [Abstract][Full Text] [Related]
19. [iPSC-derived rejuvenated T-cell therapy for Epstein-Barr virus-associated lymphomas].
Ando M; Nakauchi H; Komatsu N
Rinsho Ketsueki; 2018; 59(7):932-938. PubMed ID: 30078805
[TBL] [Abstract][Full Text] [Related]
20. In Vitro Differentiation of T Cells from Murine Pluripotent Stem Cells.
Chen X; Lei F; Wang L; Xiong X; Song J
Methods Mol Biol; 2019; 2048():131-141. PubMed ID: 31396937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
